MedPath

广州顺健生物医药科技有限公司

Ownership
-
Established
2012-07-03
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Olverembatinib Tablets

Product Name
耐立克
Approval Number
国药准字H20210048
Approval Date
Nov 24, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.